Factor XIa Inhibition: Is It a Novel Alternative Antithrombotic Strategy for High-Risk ACS Patients?

Ying X. Gue; Diana A. Gorog; Gregory Y.H. Lip

doi:10.1161/CIRCULATIONAHA.122.061987

Factor XIa Inhibition: Is It a Novel Alternative Antithrombotic Strategy for High-Risk ACS Patients?

Ying X. Gue, Diana A. Gorog, Gregory Y.H. Lip

Research output: Contribution to journal › Editorial › peer-review

Original language	English
Pages (from-to)	1207-1209
Number of pages	3
Journal	Circulation
Volume	146
Issue number	16
Early online date	27 Aug 2022
DOIs	https://doi.org/10.1161/CIRCULATIONAHA.122.061987
Publication status	Published - 18 Oct 2022

Keywords

acute coronary syndrome
Editorials
factor XIa
hemorrhage

Access to Document

10.1161/CIRCULATIONAHA.122.061987Licence: Unspecified

Accepted_Manuscript
© 2022 American Heart Association, Inc. This is the accepted manuscript version of an Editorial which has been published in final form at https://doi.org/10.1161/CIRCULATIONAHA.122.061987
Accepted author manuscript, 176 KBLicence: Unspecified

Cite this

@article{8d8ab88a5b1a4a87a79f5d80cbcae67a,

title = "Factor XIa Inhibition: Is It a Novel Alternative Antithrombotic Strategy for High-Risk ACS Patients?",

keywords = "acute coronary syndrome, Editorials, factor XIa, hemorrhage",

author = "Gue, {Ying X.} and Gorog, {Diana A.} and Lip, {Gregory Y.H.}",

note = "{\textcopyright} 2022 American Heart Association, Inc. This is the accepted manuscript version of an Editorial which has been published in final form at https://doi.org/10.1161/CIRCULATIONAHA.122.061987",

year = "2022",

month = oct,

day = "18",

doi = "10.1161/CIRCULATIONAHA.122.061987",

language = "English",

volume = "146",

pages = "1207--1209",

journal = "Circulation",

issn = "0009-7322",